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ITDemise of a vital resourceEugene H. Blackstone, MDThe US Social Security Administration’s (SSA) DeathMas-
ter File (SSDMF) has been an important source of vital sta-
tus for clinical researchers. It is sensitive and specific,1,2
reasonably up to date, and inexpensive. On November 1,
2011, this resource disappeared as a tool for biomedical
research.WHY SHOULDWE CARE?
Active follow-up of patients after cardiothoracic surgery
is costly, and the advent of restrictions on the Health Insur-
ance Portability and Accountability Act made it even more
difficult and costly for less yield. Thus, alternatives for at
least vital status have been sought. The Centers for Disease
Control and Prevention (CDC) National Death Index (NDI)
is one such source. However, it requires a proposal, initia-
tion and setup fees, as well as transfer of protected health
information for processing at the CDC, with a variable
cost per patient per year, depending on how accurate amatch
is specified. For even modest-sized studies, this can amount
to many tens of thousands of dollars.
In contrast to the NDI, the SSDMF has been a publicly
distributed resource for vital status. Centers write their
own queries against the file, with no need for external re-
quests or transfer of patient data.
Numerous publications in many medical fields have used
the SSDMF, usually calling it the ‘‘Social Security Death
Index’’ (SSDI). The Society of Thoracic Surgeons has
linked its database to the SSDMF to ascertain 30-day and
longer mortality information3; the Northern New England
Cardiovascular Disease Study Group has used it to study
the association of perioperative transfusions and long-
term survival after cardiac surgery4 and of risk factors after
cardiac valve surgery5; Emory University investigators
have used it to study survival after hybrid coronary revascu-
larization6 and impact of body mass index on mortality7;
Northwestern University surgeons have studied periopera-
tive statin therapy and survival8; the Cardiopulmonary Re-
search Science and Technology Institute has used it to study
reliability of risk algorithms in predicting mortality after
aortic valve replacement9; and we at Cleveland Clinic
have routinely used it to supplement active follow-up forHead, Clinical Investigations, Heart and Vascular Institute, Cleveland Clinic, Cleve-
land, Ohio.
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The Journal of Thoracic and Ca number of years, beginning with the study of chronic as-
pirin therapy and long-term survival after coronary artery
bypass grafting.10
Thus, this is an important resource for understanding
long-term outcomes after therapy in an efficient, inexpen-
sive manner.WHY IS THIS HAPPENING?
The SSDMF as distributed by the National Technical In-
formation Service contains a mix of vital status information
from federal and state sources. The SSA recently deter-
mined that death information from states cannot be redis-
closed except to federal benefit-paying agencies.
Information obtained from states constitutes approxi-
mately 40% of the records. These records will be expunged
from the SSDMF! This renders the SSDMF useless for bio-
medical research.WHAT CAN BE DONE?
It appears that nothing can prevent the demise of this im-
portant source of vital status short of a stay while the matter
is being investigated and possible alternatives put into place
or swift action on the part of all states and territories. Other
possibilities have been explored with the SSA, but to no
avail as of this writing.IS THERE AN ALTERNATIVE?
The NDI is more accurate than the SSDI because it uses
state-reported death certificate data. However, it is 3 years
behind and has been out of financial reach for most investi-
gators for the reasons described above. Could the CDC offer
an alternative to the SSDMF that could be distributed by
subscription to researchers on a monthly basis, as the
SSDMF is currently? It could contain the accurate NDI
data known to date, supplemented by up-to-date SSA
data. The latter would gradually be replaced by state data
as more accurate information is received. This would
make the information even more accurate than the present
SSDMF and more timely than the NDI. Distribution to sub-
scribing investigators would keep protected health informa-
tion secure.WHAT CAN RESEARCHERS DO?
I believe that only a grass-roots uprising of the biomedi-
cal community, medical societies, lobbyists, and congress-
persons can save the SSDI or stimulate a CDC equivalent.
Might this be one of those proverbial situations where it
will take ‘‘an act of Congress?’’ardiovascular Surgery c Volume 143, Number 1 37
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